Summary
MRI preferred to CT where greater tissue contrast
is required, or where no contrast agent
administered
Response criteria allow standardised reporting in
clinical trials but have limitations
Physiological sequences may be helpful in Phase I
trials to demonstrate biological effect e.g. anti-
vascular
MRI has a role in response assessment in the
clinical pathway